N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients.
Saved in:
| Title: | N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients. |
|---|---|
| Authors: | Jalaleddine N; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Hachim M; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Al-Hroub H; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates., Saheb Sharif-Askari N; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates., Senok A; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Elmoselhi A; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates., Mahboub B; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.; Department of Pulmonary Medicine and Allergy and Sleep Medicine, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates., Samuel Kurien NM; Department of Pulmonary Medicine and Allergy and Sleep Medicine, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates., Kandasamy RK; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.; Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway., Semreen MH; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates., Halwani R; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.; Prince Abdullah Ben Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates., Soares NC; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates., Al Heialy S; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.; Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada. |
| Source: | Frontiers in immunology [Front Immunol] 2022 May 19; Vol. 13, pp. 827603. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2022.827603 |
